Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrishan S Samuel

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|February 26, 2020
Inflammasomes-A Molecular Link for Altered Immunoregulation and Inflammation Mediated Vascular Dysfunction in PreeclampsiaPadma Murthi, Anita A Pinar, Evdokia Dimitriadis, et al.
Clinical Science (London, England : 1979)|November 5, 2017
Relaxin contributes to the regulation of arterial pressure in adult female miceKatrina M Mirabito Colafella, Chrishan S Samuel, Kate M Denton
British Journal of Pharmacology|May 11, 2021
Preclinical rodent models of cardiac fibrosisYan Wang, Miao Wang, Chrishan S Samuel, et al.
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung DiseasesSimon G Royce, Ross A D Bathgate, Chrishan S Samuel
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 16, 2003
Relaxin is a key mediator of prostate growth and male reproductive tract developmentChrishan S Samuel, Hongsheng Tian, Ling Zhao, et al.
Molecular and Cellular Endocrinology|December 29, 2018
Understanding relaxin signalling at the cellular levelAdam L Valkovic, Ross Ad Bathgate, Chrishan S Samuel, et al.
Frontiers in Pharmacology|August 28, 2020
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1Anita A Pinar, Alexander Yuferov, Tracey A Gaspari, et al.
Endocrinology|April 5, 2008
Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathyChrishan S Samuel, Tim D Hewitson, Yuan Zhang, et al.
Pharmacology & Therapeutics|February 16, 2018
Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseasesMaggie Lam, Simon G Royce, Chrishan S Samuel, et al.
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|February 26, 2020
Inflammasomes-A Molecular Link for Altered Immunoregulation and Inflammation Mediated Vascular Dysfunction in PreeclampsiaPadma Murthi, Anita A Pinar, Evdokia Dimitriadis, et al.
Clinical Science (London, England : 1979)|November 5, 2017
Relaxin contributes to the regulation of arterial pressure in adult female miceKatrina M Mirabito Colafella, Chrishan S Samuel, Kate M Denton
British Journal of Pharmacology|May 11, 2021
Preclinical rodent models of cardiac fibrosisYan Wang, Miao Wang, Chrishan S Samuel, et al.
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung DiseasesSimon G Royce, Ross A D Bathgate, Chrishan S Samuel
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 16, 2003
Relaxin is a key mediator of prostate growth and male reproductive tract developmentChrishan S Samuel, Hongsheng Tian, Ling Zhao, et al.
Molecular and Cellular Endocrinology|December 29, 2018
Understanding relaxin signalling at the cellular levelAdam L Valkovic, Ross Ad Bathgate, Chrishan S Samuel, et al.
Frontiers in Pharmacology|August 28, 2020
Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1Anita A Pinar, Alexander Yuferov, Tracey A Gaspari, et al.
Endocrinology|April 5, 2008
Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathyChrishan S Samuel, Tim D Hewitson, Yuan Zhang, et al.
Pharmacology & Therapeutics|February 16, 2018
Serelaxin as a novel therapeutic opposing fibrosis and contraction in lung diseasesMaggie Lam, Simon G Royce, Chrishan S Samuel, et al.
Pageof 18